Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
1-15 February 2010  
Untitled Document
Sections

Market
Management
Pharma Ally
Research
Pharma Life
Pharma Technology Review

Specials

Pharma Bio Career Guide 2009
Express Biotech

Services
Editorial Advisory Board
Open Forum
Subscribe/Renew
Archives
Media Kit
Contact Us
Network Sites
Express Computer
Express Channel Business
Express Hospitality
Express TravelWorld
Express Healthcare
Group Sites
ExpressIndia
Indian Express
Financial Express



Home - Market - Article

Company Watch

Troikaa Pharma to enhance marketing capabilities

Usha Sharma - Mumbai

Ahmedabad based mid sized pharma company Troikaa Pharmaceuticals is enlarging its marketing presence both in domestic and international markets. The company has planned to open two new divisions in India for pain management and diabetes by end April 2010. It also has planned to extend its presence in Latin America and West Africa.

Ketan Patel, Managing Director, Troikaa Pharmaceuticals highlights company's marketing plans, saying, "Our Sanad manufacturing facility plan got delayed due to government formalities. It takes near about one and half year for conversation of agricultural land into non-agriculture land but we are expecting it will take almost two years. We are targeting that all these formalities will get over by June 2010 and our facility will be ready by 2011. From the cash flow of current year we are increasing our marketing presence both in domestic as well as in the international markets. We have planned to add 350-400 people to our field force and will be launching existing product portfolio to our new targeted markets which will begin by April 2010."

"We have already started product registration in respective countries and will be launching 15-20 products in Uganda, Argentina etc. In all new regions we will be going with our flagship product Dynapar AQ," Patel added.

Recently, the company has obtained patent in Australia for its novel drug delivery form of Diclofenac injections - Dynapar AQ, the world's first painless painkiller injection. Diclofenac injections are used for management of painful inflammatory conditions. Dynapar AQ is a unique high concentration, low viscosity injection of diclofenac sodium delivering the full therapeutic dose of diclofenac in just one millilitre injection volume. It is the only diclofenac injection available in PFS (pre-filled syringe) form.

Patel reveals detail note on product registration saying, "Dynapar AQ is our flagship product and we will be going everywhere with Dynapar. Our Brazilian product registration is not yet over so it may get delayed but in rest of the countries like South Africa Columbia, Chilly and Malaysia product launch will be on time. We are in the process of finalizing a marketing joint venture and the partners are in the top five players in their respective fields. Our partners will be exporting our products under the brand name of Troikaa with their field force."

From the current financial year, it is targeting to achieve total turnover of Rs 150 crore with a growth rate of nearly 40-50 percent.

u.sharma@expressindia.com

 


Untitled Document

FEEDBACK: We would love to hear from you -- what you like about our content, what you dont, and even how you think we can improve. Please send your feedback to: editorial.ep@expressindia.com


© Copyright 2001: The Indian Express Limited. All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of The Indian Express Limited. Site managed by BPD.